Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men-Reference-Cited by-同舟云学术

Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men

Published:2020 Issue:2 Volume:67 Page:153-160
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Irie Junichiro¹,Inagaki Emi²³⁴,Fujita Masataka¹,Nakaya Hideaki¹,Mitsuishi Masanori¹,Yamaguchi Shintaro¹,Yamashita Kazuya²,Shigaki Shuhei⁵,Ono Takashi⁶,Yukioka Hideo⁶,Okano Hideyuki⁴⁷,Nabeshima Yo-ichi⁸,Imai Shin-ichiro⁸⁹,Yasui Masato⁷¹⁰,Tsubota Kazuo²⁷,Itoh Hiroshi¹⁷

Affiliation:

1. Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan

2. Department of Ophthalmology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan

3. Japan Society for the Promotion of Science, Chiyoda, Tokyo 102- 0083, Japan

4. Department of Physiology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan

5. Biomarker Research and Development Department, Shionogi & Co., Ltd., Toyonaka, Osaka 561-0825, Japan

6. Drug Discovery and Disease Research Laboratory, Shionogi & Co., Ltd, Toyonaka, Osaka 561-0825, Japan

7. Keio University Global Research Institute (KGRI), Minato, Tokyo 108-8345, Japan

8. Laboratory of Molecular Life Science, Department of Gerontology, Institute of Biomedical Research and Innovation, Kobe, Hyogo 650-0047, Japan

9. Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110, USA

10. Department of Pharmacology, Keio University School of Medicine, Shinjuku, Tokyo 160-8582, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/67/2/67_EJ19-0313/_pdf

Reference21 articles.

1. 1 Imai S, Guarente L (2014) NAD⁺ and sirtuins in aging and disease. Trends Cell Biol 24: 464–471.

2. 2 Yoshino J, Baur JA, Imai S (2018) NAD⁺ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab 27: 513–528.

3. 3 Hasegawa K, Wakino S, Simic P, Sakamaki Y, Minakuchi H, et al. (2013) Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med 19: 1496–1504.

4. 4 Mills KF, Yoshida S, Stein LR, Grozio A, Kubota S, et al. (2016) Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab 24: 795–806.

5. 5 Lin JB, Kubota S, Ban N, Yoshida M, Santeford A, et al. (2016) NAMPT-mediated NAD⁺ biosynthesis is essential for vision in mice. Cell Rep 17: 69–85.

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotinamide Mononucleotide: Research Process in Cardiovascular Diseases;International Journal of Molecular Sciences;2024-09-02

2. NAD+ metabolism and therapeutic strategies in cardiovascular diseases;Atherosclerosis Plus;2024-09

3. Advancements in NMN biotherapy and research updates in the field of digestive system diseases;Journal of Translational Medicine;2024-08-30

4. Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials;Cureus;2024-08-01

5. Anti-aging effects of medicinal plants and their rapid screening using the nematode Caenorhabditis elegans;Phytomedicine;2024-07